WES MOORE, Governor Ch. 759
Chapter 759
(House Bill 1131)
AN ACT concerning
Public Health – Buprenorphine – Training Grant Program and Workgroup
FOR the purpose of establishing the Buprenorphine Training Grant Program to assist
counties with offsetting the cost of training paramedics to administer buprenorphine;
including the Program as an authorized use of funding from the Opioid Restitution
Fund; requiring the Maryland Office of Overdose Response to convene a workgroup
to study access to buprenorphine in the State; and generally relating to
buprenorphine.
BY adding to
Article – Health – General
Section 13–5501 and 13–5502 to be under the new subtitle “Subtitle 55.
Buprenorphine Training Grant Program”
Annotated Code of Maryland
(2023 Replacement Volume and 2024 Supplement)
BY repealing and reenacting, without amendments,
Article – State Finance and Procurement
Section 7–331(a) through (e)
Annotated Code of Maryland
(2021 Replacement Volume and 2024 Supplement)
BY repealing and reenacting, with amendments,
Article – State Finance and Procurement
Section 7–331(f)
Annotated Code of Maryland
(2021 Replacement Volume and 2024 Supplement)
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
That the Laws of Maryland read as follows:
Article – Health – General
SUBTITLE 55. BUPRENORPHINE TRAINING GRANT PROGRAM.
13–5501.
(A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE THE MEANINGS
INDICATED.
– 1 –

Ch. 759 2025 LAWS OF MARYLAND
(B) “PARAMEDIC” HAS THE MEANING STATED IN § 13–516 OF THE
EDUCATION ARTICLE.
(C) “PROGRAM” MEANS THE BUPRENORPHINE TRAINING GRANT
PROGRAM.
13–5502.
(A) (1) THERE IS A BUPRENORPHINE TRAINING GRANT PROGRAM IN
THE DEPARTMENT.
(2) THE PURPOSE OF THE PROGRAM IS TO ASSIST A COUNTY WITH
OFFSETTING THE COST OF TRAINING PARAMEDICS TO ADMINISTER
BUPRENORPHINE.
(B) A COUNTY MAY APPLY TO THE DEPARTMENT FOR A GRANT FROM THE
PROGRAM.
(C) A COUNTY MAY USE A GRANT AWARDED UNDER THE PROGRAM ONLY
FOR TRAINING PARAMEDICS TO ADMINISTER BUPRENORPHINE.
(D) THE GOVERNOR SHALL INCLUDE IN THE ANNUAL BUDGET BILL AN
APPROPRIATION OF AT LEAST $50,000 FROM THE OPIOID RESTITUTION FUND FOR
THE PROGRAM.
Article – State Finance and Procurement
7–331.
(a) In this section, “Fund” means the Opioid Restitution Fund.
(b) There is an Opioid Restitution Fund.
(c) The purpose of the Fund is to retain the amount of settlement revenues
deposited to the Fund in accordance with subsection (e)(1) of this section.
(d) (1) The Fund is a special, nonlapsing fund that is not subject to § 7–302 of
this subtitle.
(2) The State Treasurer shall hold the Fund separately, and the
Comptroller shall account for the Fund.
(e) The Fund consists of:
– 2 –

WES MOORE, Governor Ch. 759
(1) all revenues received by the State from any source resulting, directly or
indirectly, from any judgment against, or settlement with, opioid manufacturers, opioid
research associations, or any other person in the opioid industry relating to any claims
made or prosecuted by the State to recover damages for violations of State law; and
(2) the interest earnings of the Fund.
(f) The Fund may be used only to provide funds for:
(1) programs, services, supports, and resources for evidence–based
substance use disorder prevention, treatment, recovery, or harm reduction that have the
purpose of:
(i) improving access to medications proven to prevent or reverse an
overdose, including by supporting the initiative to co–locate naloxone with automated
external defibrillators placed in public buildings under § 13–518 of the Education Article;
(ii) supporting peer support specialists and screening, brief
intervention, and referral to treatment services for hospitals, correctional facilities, and
other high–risk populations;
(iii) increasing access to medications that support recovery from
substance use disorders;
(iv) expanding the Heroin Coordinator Program, including for
administrative expenses;
(v) expanding access to crisis beds and residential treatment
services for adults and minors;
(vi) expanding and establishing safe stations, mobile crisis response
systems, and crisis stabilization centers;
(vii) supporting the behavioral health crisis hotline;
(viii) organizing primary and secondary school education campaigns
to prevent opioid use, including for administrative expenses;
(ix) enforcing the laws regarding opioid prescriptions and sales,
including for administrative expenses;
(x) research regarding and training for substance use treatment and
overdose prevention, including for administrative expenses; and
(xi) supporting and expanding other evidence–based interventions
for overdose prevention and substance use treatment;
– 3 –

Ch. 759 2025 LAWS OF MARYLAND
(2) supporting community–based nonprofit recovery organizations that
provide nonclinical substance use recovery support services in the State;
(3) evidence–informed substance use disorder prevention, treatment
recovery, or harm reduction pilot programs or demonstration studies that are not
evidence–based if the Opioid Restitution Fund Advisory Council, established under §
7.5–902 of the Health – General Article:
(i) determines that emerging evidence supports the distribution of
money for the pilot program or that there is a reasonable basis for funding the
demonstration study with the expectation of creating an evidence–based program; and
(ii) approves the use of money for the pilot program or demonstration
study; [and]
(4) evaluations of the effectiveness and outcomes reporting for substance
use disorder abatement infrastructure, programs, services, supports, and resources for
which money from the Fund was used, including evaluations of the impact on access to
harm reduction services or treatment for substance use disorders and the reduction in
drug–related mortality; AND
(5) THE BUPRENORPHINE TRAINING GRANT PROGRAM
ESTABLISHED UNDER § 13–5502 OF THE HEALTH – GENERAL ARTICLE.
SECTION 2. AND BE IT FURTHER ENACTED, That:
(a) The Maryland Office of Overdose Response shall convene a workgroup to
study access to buprenorphine in the State.
(b) The workgroup shall include:
(1) one member of the Senate of Maryland, appointed by the President of
the Senate;
(2) one member of the House of Delegates, appointed by the Speaker of the
House; and
(3) representatives of:
(i) the Maryland Institute of Emergency Medical Services Systems;
(ii) the Behavioral Health Administration;
(iii) hospitals;
– 4 –

WES MOORE, Governor Ch. 759
(iv) local behavioral health agencies; and
(v) the Maryland Association of Counties.
(c) The workgroup shall examine:
(1) how buprenorphine services are offered in the State;
(2) the capacity of providers to provide buprenorphine;
(3) any geographic areas where significant gaps in buprenorphine services
may exist;
(4) the feasibility of financial support for a long–term expansion of
buprenorphine services;
(5) a plan for ongoing data collection for the purpose of the monitoring and
improvement of buprenorphine services;
(6) how to effectively grow a hub–and–spoke model to ensure access to
buprenorphine in the State; and
(7) any other strategies that would improve buprenorphine services in the
State.
(d) On or before December 31, 2025, the Maryland Office of Overdose Response
shall submit a report on the findings and recommendations of the workgroup, including the
need for any statutory changes, to the Governor and, in accordance with § 2–1257 of the
State Government Article, the Senate Finance Committee and the House Health and
Government Operations Committee.
SECTION 3. AND BE IT FURTHER ENACTED, That Section 1 of this Act shall take
effect October 1, 2025. Section 1 of this Act shall remain in effect for a period of 5 years and,
at the end of September 30, 2030, Section 1 of this Act, with no further action required by
the General Assembly, shall be abrogated and of no further force and effect.
SECTION 4. AND BE IT FURTHER ENACTED, That, except as provided in Section
3 of this Act, this Act shall take effect July 1, 2025. Section 2 of this Act shall remain
effective for a period of 1 year and, at the end of June 30, 2026, Section 2 of this Act, with
no further action required by the General Assembly, shall be abrogated and of no further
force and effect.
Approved by the Governor, May 20, 2025.
– 5 –

[DELETED: W C t p o e t B T G P t a s a t b i t S a g r tA 1 a 1 t b u t n s “ 5A(ASA(ASA(S5.BTGP.  U R R R) N T S T F W H T M]
[DELETED:  2 () “P”§1AC H T M S I   O TA. R() “P”BTRM M T U R R.() ( TBTGH I A U R R R I E. ( T R T C O T P T A() A  E() A  RE() TH O S I I T A B B A   P E U0OR RM.( I( T( T p o t F i t r t a o s r( ( T ( T S T s h t F s a t( T]
[DELETED: W C ( a ( t( T ( p s s a r f e  ( i i b s t i t c n w a  ( s p s s a s b  ( i a t m t s r f  ( e t H C P i f  ( e a t c b a r t  ( e  ( s  ( o  ( e t l r o p a s  ( r  ( s a e o e i]
[DELETED:  2  ( s c n r o t ( e s u d p t o h r p p o d s t a n i t O R F A C e u §  ( d f t p p o t t i a r b f f t  ( a a] ( e d a i p s s a r f sy ( BTG U R R R    E  E R12H–GAS( T M O o O R s c a w t( T ( o ( o ( r  ( t  ( t  ( h]
[DELETED: W C  ( l  ( t( T ( h ( t ( a ( t f o f s f a l e o ( a ( h t e g a h m t e a t ( a( O G A t S F C a t H H aSS]